Prevalence of liver cancer in Kazakhstan: a systematic review

2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3329/bjms.v23i3.75020
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Background The study aimed to study the relative and absolute indicators of liver cancer (C22) in Kazakhstan over 10 years in the prism of a trend indicator (moving average), coefficient of variation (Cv), accounting reliability index (Idi).In 2022, in Kazakhstan, the incidence of liver cancer (C22) was 5.1 per 100 thousand people, mortality was 2.9, respectively, the index of reliability of accounting was 0.2.The unified risk of morbidity of the population of Kazakhstan with liver cancer for the period 2013-2022 amounted to 28.6%, mortality - 33.5%, respectively. Result Over the period 2013-2022, newly diagnosed liver cancer in Kazakhstan increased by 31%, the rate of decrease in the number of newly diagnosed liver cancers varied unevenly over the years, which demonstrates a high rate and amplitude of change from 105 to -140, which significantly complicates the prediction of this pathology. Conclusion: For the period 2013-2022, posthumously registered liver cancer consistently occupied the first place in the structure of specific gravity among all malignant neoplasms in Kazakhstan. Bangladesh Journal of Medical Science Vol. 23 No. 03 July’24 Page : 643-654